Therapy is a treatment option for adults with severe and moderately severe haemophilia B
News
Theriva Biologics reveals positive VCN-01 study results
The candidate is a stroma-degrading oncolytic adenovirus for the treatment of pancreatic cancer
Metrion Biosciences boosts hERG screening service
MHRA has made the company a member of the UK GLP compliance monitoring programme
Partnership aims to boost mental health research
The University of Strathclyde, the NHS and New York University join forces to increase knowledge
Kyowa Kirin and Grünenthal collaborate on therapy portfolio
The deal covers 13 brands across six therapeutic areas, mainly focused on pain treatment
Invizius gets MHRA Approval for H-Guard research
First-in-human study to be undertaken at the Manchester University Hospitals NHS Foundation Trust
NHS nod for Celadon cannabis medicine trial
The approval involves the roll-out of a non-cancer chronic pain study for up to 5,000 patients
Okyo reaches clinical trial agreement with Tufts
Novel therapy, OK-101, offers a potential way of relieving neuropathic corneal pain
First patient dosed in Immutep’s soft tissue sarcoma trial
The phase 2 study involves company’s eftilagimod alpha therapy
TVM and Tillotts form company to take on ulcerative colitis
Mage Biologics aims to progress a novel, orally administered monoclonal antibody
Abionyx manufactures a new batch of ApoA-I CER-001
The vital second batch represents a critical step on the candidate’s pathway to regulatory approval
First dose completed in phase 1 cannabinoid study
OCTP aims to demonstrate the lead candidate’s safety, tolerability and pharmacokinetic profile
ABPI reacts to new vital vaccination report
New HSCC document deems the UK’s vaccination position to be at risk
Vantage Biosciences launched to take on diabetic eye disease
The new company’s core mission is to boost patient access to disease-modifying treatments
MSD’s HCV report calls for key elimination boosts
The advice includes a national rollout of the HCV GP champion programme and further testing
